Work

PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS

Year: 2019

Type: article

Source: Hematological Oncology

DOI: 10.1002/hon.145_2630

Authors: C.J. Melani, R. Lakhotia, S. Pittaluga, M.D. Miljkovic, C.A. Portell, R.J. Farah, A.M. Juanitez, L.L. Chou, S.M. Steinberg, E.S. Jaffe, L.M. Staudt, M.J. Roschewski, W.H. Wilson

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, University of Virginia Cancer Center, University of Virginia, University of Pittsburgh

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2949449378

FWCI: 0.314

Cites:

Cited by: 2

Related to: 10